KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Asset Writedowns and Impairment (2023 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with -$1.2 million as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment fell 117.84% to -$1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.1 million through Sep 2025, down 63.45% year-over-year, with the annual reading at $8.9 million for FY2024, 56.06% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was -$1.2 million at Supernus Pharmaceuticals, down from -$239000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $20.2 million in Q4 2023, with the low at -$1.2 million in Q4 2025.
  • Average Asset Writedowns and Impairment over 3 years is $3.2 million, with a median of $730000.0 recorded in 2024.
  • Peak annual rise in Asset Writedowns and Impairment hit 25.07% in 2025, while the deepest fall reached 724.14% in 2025.
  • Over 3 years, Asset Writedowns and Impairment stood at $20.2 million in 2023, then crashed by 65.93% to $6.9 million in 2024, then crashed by 117.84% to -$1.2 million in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at -$1.2 million, -$239000.0, and $920000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.